These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 19549254)
1. Expression of KAI1/CD82 in distant metastases from estrogen receptor-negative breast cancer. Christgen M; Christgen H; Heil C; Krech T; Länger F; Kreipe H; Lehmann U Cancer Sci; 2009 Sep; 100(9):1767-71. PubMed ID: 19549254 [TBL] [Abstract][Full Text] [Related]
2. KAI1/CD82 is a novel target of estrogen receptor-mediated gene repression and downregulated in primary human breast cancer. Christgen M; Bruchhardt H; Ballmaier M; Krech T; Länger F; Kreipe H; Lehmann U Int J Cancer; 2008 Nov; 123(10):2239-46. PubMed ID: 18712725 [TBL] [Abstract][Full Text] [Related]
3. KAI1/CD82 and MRP1/CD9 serve as markers of infiltration, metastasis, and prognosis in laryngeal squamous cell carcinomas. Zhang BH; Liu W; Li L; Lu JG; Sun YN; Jin DJ; Xu XY Asian Pac J Cancer Prev; 2013; 14(6):3521-6. PubMed ID: 23886139 [TBL] [Abstract][Full Text] [Related]
4. Down Regulation of KAI1/CD82 in Lymph Node Positive and Advanced T-Stage Group in Breast Cancer Patients. Krishna Latha T; Verma A; Thakur GK; Banerjee B; Kaur N; Singh UR; Sharma S Asian Pac J Cancer Prev; 2019 Nov; 20(11):3321-3329. PubMed ID: 31759355 [TBL] [Abstract][Full Text] [Related]
5. Correlation of reduction in MRP-1/CD9 and KAI1/CD82 expression with recurrences in breast cancer patients. Huang CI; Kohno N; Ogawa E; Adachi M; Taki T; Miyake M Am J Pathol; 1998 Sep; 153(3):973-83. PubMed ID: 9736046 [TBL] [Abstract][Full Text] [Related]
6. miR-1290 and its potential targets are associated with characteristics of estrogen receptor α-positive breast cancer. Endo Y; Toyama T; Takahashi S; Yoshimoto N; Iwasa M; Asano T; Fujii Y; Yamashita H Endocr Relat Cancer; 2013 Feb; 20(1):91-102. PubMed ID: 23183268 [TBL] [Abstract][Full Text] [Related]
7. Expression and clinical significance of CD82/KAI1 and E-cadherin in non-small cell lung cancer. Shiwu WU; Lan Y; Wenqing S; Lei Z; Yisheng T Arch Iran Med; 2012 Nov; 15(11):707-12. PubMed ID: 23102249 [TBL] [Abstract][Full Text] [Related]
8. Limited value of KAI1/CD82 protein expression as a prognostic marker in human gastric cancer. Knoener M; Krech T; Puls F; Lehmann U; Kreipe H; Christgen M Dis Markers; 2012; 32(6):337-42. PubMed ID: 22684230 [TBL] [Abstract][Full Text] [Related]
9. Down-regulation of the metastasis suppressor protein KAI1/CD82 correlates with occurrence of metastasis, prognosis and presence of HPV DNA in human penile squamous cell carcinoma. Protzel C; Kakies C; Kleist B; Poetsch M; Giebel J Virchows Arch; 2008 Apr; 452(4):369-75. PubMed ID: 18305955 [TBL] [Abstract][Full Text] [Related]
10. Identifying CD82 (KAI1) as a marker for human chromophobe renal cell carcinoma. Yusenko MV; Kovacs G Histopathology; 2009 Dec; 55(6):687-95. PubMed ID: 20002769 [TBL] [Abstract][Full Text] [Related]
12. KAI1, a putative marker for metastatic potential in human breast cancer. Yang X; Welch DR; Phillips KK; Weissman BE; Wei LL Cancer Lett; 1997 Nov; 119(2):149-55. PubMed ID: 9570365 [TBL] [Abstract][Full Text] [Related]
13. Re: KAI1/CD82 is a novel target of estrogen receptor-mediated gene repression and downregulated in primary human breast cancer (Int J Cancer 123: 2239-2246, 2008). Geradts J Int J Cancer; 2009 May; 124(9):2243-4; author reply 2245. PubMed ID: 19115215 [No Abstract] [Full Text] [Related]
14. Effect of expressional alteration of KAI1 on breast cancer cell growth, adhesion, migration and invasion. Malik FA; Sanders AJ; Kayani MA; Jiang WG Cancer Genomics Proteomics; 2009; 6(4):205-13. PubMed ID: 19656997 [TBL] [Abstract][Full Text] [Related]
15. CD82/KAI1 inhibits invasion and metastasis of esophageal squamous cell carcinoma via TGF-β1. Zeng TD; Zheng B; Zheng W; Chen C Eur Rev Med Pharmacol Sci; 2018 Sep; 22(18):5928-5937. PubMed ID: 30280774 [TBL] [Abstract][Full Text] [Related]
16. KAI1/CD82 and cyclin D1 as biomarkers of invasion, metastasis and prognosis of laryngeal squamous cell carcinoma. Zhang B; Liu W; Li L; Lu J; Liu M; Sun Y; Jin D Int J Clin Exp Pathol; 2013; 6(6):1060-7. PubMed ID: 23696923 [TBL] [Abstract][Full Text] [Related]
17. Clinicopathological significance of cancer stem cells marked by CD133 and KAI1/CD82 expression in laryngeal squamous cell carcinoma. Yu L; Zhou L; Wu S; Gong X; Feng Z; Ma L; Zhu B; Yao N; Wang D; Dong H World J Surg Oncol; 2014 Apr; 12():118. PubMed ID: 24758564 [TBL] [Abstract][Full Text] [Related]
18. OLFM4, LY6D and S100A7 as potent markers for distant metastasis in estrogen receptor-positive breast carcinoma. Mayama A; Takagi K; Suzuki H; Sato A; Onodera Y; Miki Y; Sakurai M; Watanabe T; Sakamoto K; Yoshida R; Ishida T; Sasano H; Suzuki T Cancer Sci; 2018 Oct; 109(10):3350-3359. PubMed ID: 30137688 [TBL] [Abstract][Full Text] [Related]
19. Decreased expression of KAI1/CD82 metastasis suppressor gene is associated with loss of heterozygosity in melanoma cell lines. Kim YI; Shin MK; Lee JW; Chung JH; Lee MH Oncol Rep; 2009 Jan; 21(1):159-64. PubMed ID: 19082457 [TBL] [Abstract][Full Text] [Related]
20. Expression and clinical significance of p53, JunB and KAI1/CD82 in human hepatocellular carcinoma. Guo C; Liu QG; Zhang L; Song T; Yang X Hepatobiliary Pancreat Dis Int; 2009 Aug; 8(4):389-96. PubMed ID: 19666408 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]